Association of rs4646903 and rs1048943 CYP1A1 estrogen-metabolizing gene polymorphisms with estrogen receptor-positive breast cancer in Kenyan women

Breast cancer is the most prevalent neoplasm and the second leading cause of death among females in Kenya. Estrogen and its metabolites are known risk factors for breast cancer. Polymorphisms in these genes and breast cancer susceptibility are unique among different populations. This study aimed to...

Full description

Bibliographic Details
Main Authors: Murithi Mary, Nyanjom Steven, Mobegi Victor, Shahin Sayed, Makokha Francis
Format: Article
Language:English
Published: University of Belgrade, University of Novi Sad 2023-01-01
Series:Archives of Biological Sciences
Subjects:
Online Access:https://doiserbia.nb.rs/img/doi/0354-4664/2023/0354-46642300005M.pdf
_version_ 1797807609521111040
author Murithi Mary
Nyanjom Steven
Mobegi Victor
Shahin Sayed
Makokha Francis
author_facet Murithi Mary
Nyanjom Steven
Mobegi Victor
Shahin Sayed
Makokha Francis
author_sort Murithi Mary
collection DOAJ
description Breast cancer is the most prevalent neoplasm and the second leading cause of death among females in Kenya. Estrogen and its metabolites are known risk factors for breast cancer. Polymorphisms in these genes and breast cancer susceptibility are unique among different populations. This study aimed to determine the probable associations between estrogen-metabolizing gene variations and other risk factors for breast cancer risk in Kenyan women. Buffy coat samples were obtained from patients diagnosed with estrogen receptor-positive breast cancer, benign breast disease, and healthy volunteers. Genotyping of target polymorphisms was conducted using polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) analysis. The rs4646903 variant genotype CC was associated with breast cancer in the case-control model (P=0.001); the heterozygous genotype TC (P=0.01) and the luminal B molecular subtype (P=0.02) showed increased odds of late-stage breast cancer. The rs1048943 variant genotype GG was associated with breast cancer in the case-benign model (P=0.04), whereas CG was associated with breast cancer in the case-control model (P=0.02). These findings imply that the rs4646903 and rs1048943 variant genotypes are involved in breast cancer risk in Kenyan women. Hence, they may be explored further as potential markers for the disease.
first_indexed 2024-03-13T06:25:09Z
format Article
id doaj.art-c696746ff53f4256947b5e90f2c9123c
institution Directory Open Access Journal
issn 0354-4664
1821-4339
language English
last_indexed 2024-03-13T06:25:09Z
publishDate 2023-01-01
publisher University of Belgrade, University of Novi Sad
record_format Article
series Archives of Biological Sciences
spelling doaj.art-c696746ff53f4256947b5e90f2c9123c2023-06-09T10:41:58ZengUniversity of Belgrade, University of Novi SadArchives of Biological Sciences0354-46641821-43392023-01-01751576710.2298/ABS230115005M0354-46642300005MAssociation of rs4646903 and rs1048943 CYP1A1 estrogen-metabolizing gene polymorphisms with estrogen receptor-positive breast cancer in Kenyan womenMurithi Mary0Nyanjom Steven1Mobegi Victor2Shahin Sayed3Makokha Francis4Biochemistry Department, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya + Pre-Clinical Department, Kabarak University, Nakuru, KenyaBiochemistry Department, Jomo Kenyatta University of Agriculture and Technology, Nairobi, KenyaDepartment of Biochemistry, University of Nairobi, Nairobi, KenyaDepartment of Pathology, Aga Khan University Hospital, Nairobi, KenyaDirectorate of Research and Innovation, Mount Kenya University, Thika, KenyaBreast cancer is the most prevalent neoplasm and the second leading cause of death among females in Kenya. Estrogen and its metabolites are known risk factors for breast cancer. Polymorphisms in these genes and breast cancer susceptibility are unique among different populations. This study aimed to determine the probable associations between estrogen-metabolizing gene variations and other risk factors for breast cancer risk in Kenyan women. Buffy coat samples were obtained from patients diagnosed with estrogen receptor-positive breast cancer, benign breast disease, and healthy volunteers. Genotyping of target polymorphisms was conducted using polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) analysis. The rs4646903 variant genotype CC was associated with breast cancer in the case-control model (P=0.001); the heterozygous genotype TC (P=0.01) and the luminal B molecular subtype (P=0.02) showed increased odds of late-stage breast cancer. The rs1048943 variant genotype GG was associated with breast cancer in the case-benign model (P=0.04), whereas CG was associated with breast cancer in the case-control model (P=0.02). These findings imply that the rs4646903 and rs1048943 variant genotypes are involved in breast cancer risk in Kenyan women. Hence, they may be explored further as potential markers for the disease.https://doiserbia.nb.rs/img/doi/0354-4664/2023/0354-46642300005M.pdfbreast cancergene polymorphismsestrogen metabolizing genepolymerase chain reaction-restriction fragment length polymorphismgenotype
spellingShingle Murithi Mary
Nyanjom Steven
Mobegi Victor
Shahin Sayed
Makokha Francis
Association of rs4646903 and rs1048943 CYP1A1 estrogen-metabolizing gene polymorphisms with estrogen receptor-positive breast cancer in Kenyan women
Archives of Biological Sciences
breast cancer
gene polymorphisms
estrogen metabolizing gene
polymerase chain reaction-restriction fragment length polymorphism
genotype
title Association of rs4646903 and rs1048943 CYP1A1 estrogen-metabolizing gene polymorphisms with estrogen receptor-positive breast cancer in Kenyan women
title_full Association of rs4646903 and rs1048943 CYP1A1 estrogen-metabolizing gene polymorphisms with estrogen receptor-positive breast cancer in Kenyan women
title_fullStr Association of rs4646903 and rs1048943 CYP1A1 estrogen-metabolizing gene polymorphisms with estrogen receptor-positive breast cancer in Kenyan women
title_full_unstemmed Association of rs4646903 and rs1048943 CYP1A1 estrogen-metabolizing gene polymorphisms with estrogen receptor-positive breast cancer in Kenyan women
title_short Association of rs4646903 and rs1048943 CYP1A1 estrogen-metabolizing gene polymorphisms with estrogen receptor-positive breast cancer in Kenyan women
title_sort association of rs4646903 and rs1048943 cyp1a1 estrogen metabolizing gene polymorphisms with estrogen receptor positive breast cancer in kenyan women
topic breast cancer
gene polymorphisms
estrogen metabolizing gene
polymerase chain reaction-restriction fragment length polymorphism
genotype
url https://doiserbia.nb.rs/img/doi/0354-4664/2023/0354-46642300005M.pdf
work_keys_str_mv AT murithimary associationofrs4646903andrs1048943cyp1a1estrogenmetabolizinggenepolymorphismswithestrogenreceptorpositivebreastcancerinkenyanwomen
AT nyanjomsteven associationofrs4646903andrs1048943cyp1a1estrogenmetabolizinggenepolymorphismswithestrogenreceptorpositivebreastcancerinkenyanwomen
AT mobegivictor associationofrs4646903andrs1048943cyp1a1estrogenmetabolizinggenepolymorphismswithestrogenreceptorpositivebreastcancerinkenyanwomen
AT shahinsayed associationofrs4646903andrs1048943cyp1a1estrogenmetabolizinggenepolymorphismswithestrogenreceptorpositivebreastcancerinkenyanwomen
AT makokhafrancis associationofrs4646903andrs1048943cyp1a1estrogenmetabolizinggenepolymorphismswithestrogenreceptorpositivebreastcancerinkenyanwomen